Cargando…
Carrying Temoporfin with Human Serum Albumin: A New Perspective for Photodynamic Application in Head and Neck Cancer
Temoporfin (mTHPC) is approved in Europe for the photodynamic treatment of head and neck squamous cell carcinoma (HNSCC). Although it has a promising profile, its lipophilic character hampers the full exploitation of its potential due to high tendency of aggregation and a reduced ROS generation that...
Autores principales: | Mattioli, Edoardo Jun, Ulfo, Luca, Marconi, Alessia, Pellicioni, Valentina, Costantini, Paolo Emidio, Marforio, Tainah Dorina, Di Giosia, Matteo, Danielli, Alberto, Fimognari, Carmela, Turrini, Eleonora, Calvaresi, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855801/ https://www.ncbi.nlm.nih.gov/pubmed/36671454 http://dx.doi.org/10.3390/biom13010068 |
Ejemplares similares
-
Identification of Blood Transport Proteins to Carry Temoporfin: A Domino Approach from Virtual Screening to Synthesis and In Vitro PDT Testing
por: Marconi, Alessia, et al.
Publicado: (2023) -
Light-Enhanced Cytotoxicity of Doxorubicin by Photoactivation
por: Greco, Giulia, et al.
Publicado: (2023) -
EGFR-Targeted Photodynamic Therapy
por: Ulfo, Luca, et al.
Publicado: (2022) -
Dissecting the Interactions between Chlorin e6 and Human Serum Albumin
por: Marconi, Alessia, et al.
Publicado: (2023) -
Spiky Gold Nanoparticles for the Photothermal Eradication of Colon Cancer Cells
por: Costantini, Paolo Emidio, et al.
Publicado: (2021)